China Already Ran This Insurance Reform Experiment, Here's What Followed
A regulatory reset that looks disruptive in the short term doesn't always stay that way
India's insurance regulator is reportedly weighing changes to how distribution costs work in the bancassurance channel, the arrangement where banks sell insurance products alongside their own. If that sounds familiar, it's because China ran almost exactly this experiment two years earlier, and the way it played out is worth understanding regardless of which side of the reform an investor ends up watching.
What China actually changed
Starting in August 2023, China's insurance regulator pushed through a rule requiring insurers to keep their actual commission payouts consistent with what they'd filed with the regulator, closing a long-standing gap between reported cost structures and what was really being paid to distributors. The immediate effect was a roughly 30 percent cut in bancassurance commissions. That was followed by two more changes over the next couple of years: banks were allowed to sell products from more insurers rather than being capped at a handful of partners, and insurers were required to disclose all distribution-related expenses explicitly in their product filings.
None of this was a single event. It was a sequence, each step tightening the gap between what the industry reported and what it actually did.
The disruption came first
The near-term effect was rough. Banks and insurers had to renegotiate their distribution agreements from scratch, and sales momentum through that channel effectively froze for a couple of quarters while the new terms got worked out. Anyone watching only that window would have reasonably concluded the reform had damaged the business.
The recovery told a different story
Within a few quarters, the bancassurance channel wasn't just recovering, it was contributing more to new business value than before the reform. Margins on products sold through the channel improved, since insurers were no longer bidding away profitability to win shelf space at banks. And the recovery wasn't evenly shared: insurers with stronger distribution networks, sturdier balance sheets and more trusted brands captured a disproportionate share of the rebound, while smaller players that had been competing mainly by paying banks more for access lost ground once that lever was regulated away.
Why this pattern is worth knowing, not just this instance
Step back from insurance specifically, and this is a recognizable shape: a regulatory change that removes an artificial cost advantage creates a sharp, visible disruption first, and a quieter, less visible redistribution of competitive strength afterward. The disruption is what gets noticed in real time. The redistribution is what actually determines who benefits once the dust settles, and it tends to favor whoever didn't need the artificial advantage to compete in the first place.
If India's insurance distribution reform follows a similar arc, and there's no guarantee it will, since regulatory specifics, market structure and timelines can all differ meaningfully between the two markets, the useful takeaway isn't a prediction about which quarter the disruption ends. It's a reminder that a sector under near-term regulatory pressure isn't automatically a sector in decline, and that watching who's still standing, and stronger, once a rule change fully plays out tends to be more informative than reacting to the initial disruption itself.